Insiders · Profile

Kordasiewicz Holly B.

EVP, Chief Development Officer at IONIS PHARMACEUTICALS. Filing since 16 Jan 2026. CIK 0002102721

Company
Date
Role
Action
Shares
Amount
Of holding
7 Jul 2026
EVP, Chief Development Officer
Sold on a plan
362
$30.52K
1.6%
12 Jun 2026
EVP, Chief Development Officer
Sold on a plan
60,846
$4.47M
73.0%
16 Jan 2026
EVP, Chief Development Officer
Sold at will
4,141
$313.31K
22.0%
3 decisions on file.